Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502) Meeting Abstract


Authors: Sinicrope, F. A.; Ou, F. S.; Zemla, T.; Nixon, A. B.; Mody, K.; Levasseur, A.; Dueck, A. C.; Dhanarajan, A. R.; Lieu, C. H.; Cohen, D. J.; Innocenti, F.; Behrens, R. J.; Peters, W.; Sommer, N.; O'Reilly, E. M.; Meyerhardt, J. A.
Abstract Title: Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repair (ATOMIC, Alliance A021502)
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Language: English
ACCESSION: WOS:000487345801177
DOI: 10.1200/JCO.2019.37.15_suppl.e15169
PROVIDER: wos
Notes: Meeting Abstract: e15169 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly